貨號(hào):GS40668
Sonelokimab is a humanized Nanobody? (single-domain antibody) targeting interleukin-17A (IL-17A) and interleukin-17F (IL-17F). It simultaneously binds and neutralizes both cytokines, which play key roles in inflammatory and autoimmune diseases. It is being developed for the treatment of moderate-to-severe plaque psoriasis and psoriatic arthritis.
武漢邁思生物科技有限公司
聯(lián)系商家時(shí)請(qǐng)?zhí)峒癱hemicalbook,有助于交易順利完成!
冉凱凱